Vol 6, No 4 (2005): Practical Diabetology
Original articles (translated)
Published online: 2005-08-23
Get Citation

The effect of ruboxistaurin on visual loss in patients with moderately severe to very severe nonproliferative diabetic retinopathy. Initial results of the Protein Kinase C beta Inhibitor Diabetic Retinopathy Study (PKC-DRS) Multicenter Randomized Clinical Trial

Grupa badawcza PKC-DRS
Diabetologia Praktyczna 2005;6(4):210-222.
Vol 6, No 4 (2005): Practical Diabetology
Original articles (translated)
Published online: 2005-08-23

Abstract

Not available

Abstract

Not available
Get Citation

Keywords

diabetic retinopathy; visual loss; ruboxistaurin

About this article
Title

The effect of ruboxistaurin on visual loss in patients with moderately severe to very severe nonproliferative diabetic retinopathy. Initial results of the Protein Kinase C beta Inhibitor Diabetic Retinopathy Study (PKC-DRS) Multicenter Randomized Clinical Trial

Journal

Clinical Diabetology

Issue

Vol 6, No 4 (2005): Practical Diabetology

Pages

210-222

Published online

2005-08-23

Bibliographic record

Diabetologia Praktyczna 2005;6(4):210-222.

Keywords

diabetic retinopathy
visual loss
ruboxistaurin

Authors

Grupa badawcza PKC-DRS

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl